T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy

CT Sibley, RA Noureldin, N Gai, MS Nacif, S Liu… - Radiology, 2012 - pubs.rsna.org
Purpose To determine the utility of cardiac magnetic resonance (MR) T1 mapping for
quantification of diffuse myocardial fibrosis compared with the standard of endomyocardial …

[HTML][HTML] Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

MS Maron - Journal of Cardiovascular Magnetic Resonance, 2012 - Elsevier
Hypertrophic cardiomyopathy (HCM) is characterized by substantial genetic and phenotypic
heterogeneity, leading to considerable diversity in clinical course including the most …

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study

SM Banypersad, DM Sado, AS Flett… - Circulation …, 2013 - Am Heart Assoc
Background—Cardiac involvement predicts outcome in systemic AL amyloidosis and
influences therapeutic options. Current methods of cardiac assessment do not quantify …

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy

L Fang, AH Ellims, X Moore, DA White… - Journal of translational …, 2015 - Springer
Background Circulating microRNAs may represent novel markers for cardiovascular
diseases. We evaluated whether circulating miRNAs served as potential biomarkers for …

Updates in cardiac amyloidosis: a review

SM Banypersad, JC Moon, C Whelan… - Journal of the …, 2012 - Am Heart Assoc
Systemic amyloidosis is a relatively rare multisystem disease caused by the deposition of
misfolded protein in various tissues and organs. It may present to almost any specialty, and …

Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI

SK Piechnik, VM Ferreira, AJ Lewandowski… - Journal of …, 2013 - Springer
Background Quantitative T1-mapping is rapidly becoming a clinical tool in cardiovascular
magnetic resonance (CMR) to objectively distinguish normal from diseased myocardium …

Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction

KP Rommel, M von Roeder, K Latuscynski… - Journal of the American …, 2016 - jacc.org
Background: Optimal patient characterization in heart failure with preserved ejection fraction
(HFpEF) is essential to tailor successful treatment strategies. Cardiac magnetic resonance …

Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications

F von Knobelsdorff-Brenkenhoff, M Prothmann… - Journal of …, 2013 - Springer
Abstract Background Myocardial T 1 and T 2 mapping using cardiovascular magnetic
resonance (CMR) are promising to improve tissue characterization and early disease …

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy

F aus dem Siepen, SJ Buss… - European Heart …, 2015 - academic.oup.com
Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …

Reverse myocardial remodeling following valve replacement in patients with aortic stenosis

TA Treibel, R Kozor, R Schofield, G Benedetti… - Journal of the American …, 2018 - jacc.org
Background: Left ventricular (LV) hypertrophy, a key process in human cardiac disease,
results from cellular (hypertrophy) and extracellular matrix expansion (interstitial fibrosis) …